Omics! Omics!

Good morning Mr. Hunt. Today's briefing will have a bit more background than usual - you haven't tangled with biotechnology since th...

Throughout the two pieces on Roche SBX sequencing I sprinkled the term “midi read sequencing”.  Here I’m going to explore in more detail thi...

In the prior piece , I covered the technical details unveiled by Roche for their SBX technology, but generally tried to avoid predicting its...

Bar bets can be a powerful force in human society.  One of the best known books on the planet, The Guinness Book of World Records, originate...

I’ve covered a lot of genomics in this space, but there is an inherent challenge to studying biology via DNA - DNA is the underlying bluepri...

If you've been in a movie theater recently, you may have seen a trailer for a mixed live action and animation spectacle called How To Tr...

Well, the embargo has passed and one of the worst kept rumors of genomics land has come true: at this year's ASHG PacBio has unveiled th...

ASHG is ongoing and tonight PacBio has a big party planned, with an unnamed musical guest.  Rumors swirl as to what will be announced at tha...

MiSeq is the the oldest instrument in Illumina's lineup, first unveiled back in 2011 .  MiSeq's launch stole much of the thunder fro...

I'm always excited by sequencing technology going bigger.  Every time the technology can generate significantly more data, experiments t...

A maxim from the great but fictional advertising executive Don Draper: "if you don't like what people are saying, change the conver...

I recently tried to place a claim that I had first conceived Oxford Nanopore's "6b4" strategy for solving homopolymers, but th...

One of the most important enzymes in the sequencing world, one which enables spectacular creativity on the part of novel assay designers, is...

Oxford Nanopore is in the process of morphing into a product-focused company, and so must identify specific markets in which they believe na...

Last month at London Calling, Oxford Nanopore announced a consumables and reagent bundle which enables generating six telomere-to-telomere (...

Scale Bioscience o fficially rolled out today - their rep was already talking about it at the Boston Single Cell Symposium I attended yester...

I have multiple drafts of posts trying to finish up my London Calling items and then a long list of ideas in various stages of gestation - a...

London Calling isn't nearly as exhausting as AGBT, but the first day of talks is packed and then follows with the social event that goes...

London Calling was a particularly good opportunity to take stock of Oxford Nanopore's progress to a "fire-and-forget" sample-t...

I'm writing this the eve of Oxford Nanopore's London Calling conference.  This is a big one, as this summer marks the 10th anniversa...